Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Zavante raises $45mm in Series A round

Executive Summary

Antibiotics developer Zavante Therapeutics Inc. raised $45mm through a Series A financing. The company sold $35mm in equity to lead investors Frazier Healthcare Partners and Longitude Capital (each VC adds a board member) as well as Aisling Capital (adds a board observer). Zavante got another $10mm by converting outstanding notes.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Convertible Debt
    • Private Placement

Related Companies